Next Article in Journal
Proteomic Dynamics in the Interaction of Susceptible and Resistant Tomato Cultivars and Potato Cyst Nematodes
Next Article in Special Issue
Introducing a Porcine Inflammatory Ex Vivo Retina Model for Diabetic Retinopathy
Previous Article in Journal
GPCR Sense Communication Among Interaction Nematodes with Other Organisms
Previous Article in Special Issue
CX3CR1–Fractalkine Dysregulation Affects Retinal GFAP Expression, Inflammatory Gene Induction, and LPS Response in a Mouse Model of Hypoxic Retinopathy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sustained Experimental Myopia Exacerbates the Effect of Eye Growth on Retinal Ganglion Cell Density and Function

by
Carol Ren Lin
,
Reynolds Kwame Ablordeppey
and
Alexandra Benavente-Perez
*
Department of Biological Sciences, SUNY College of Optometry, New York, NY 10036, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(6), 2824; https://doi.org/10.3390/ijms26062824
Submission received: 25 February 2025 / Revised: 14 March 2025 / Accepted: 16 March 2025 / Published: 20 March 2025
(This article belongs to the Special Issue Advanced Research in Retina: 3rd Edition)

Abstract

:
The aim of this study is to describe the effect that sustained myopic eye growth has on the cellular distribution and function of retinal ganglion cells as myopia progresses over time. Ganglion cell density and the photopic negative response (PhNR) were assessed using immunochemistry and electroretinography (ERG), respectively, on twelve common marmoset eyes (Callithrix jacchus). Myopia was induced in six eyes using negative defocus (three eyes from 2 to 6 months of age, 6-month-old myopes; three eyes from 2 to 12 months of age, 12-month-old myopes). These six treated eyes were compared to six age-matched control eyes. Marmosets induced with myopia for four months showed a reduced pan-retinal ganglion cell density, which continued to decrease in the peripapillary area of marmosets induced with sustained myopia for ten months. Ganglion cell density decreased as a function of axial length. Full-field ERGs revealed a dampening of the PhNR in the 12-month-old, but not 6-month-old myopes. The myopic changes observed in ganglion cell density and retinal function suggest a reorganization of the ganglion cell template during myopia development and progression that increases over time with sustained myopic eye growth and translates into functional alterations at later stages of myopia development in the absence of degenerative changes. It remains unknown whether these changes positively or negatively impact retinal function and health.

1. Introduction

Myopia causes blurred vision at distance and is a pre-eminent risk factor for retinopathies, like glaucoma and choroidal neovascularization, and various maculopathies [1,2], including myopic maculopathy, which is a leading cause of irreversible vision loss. The projected global increase in the prevalence of myopia is predicted to affect over 4.5 billion people by the year 2050 [3,4]. The myopia epidemic has become and will continue to be a significant public health crisis for communities around the world. Despite the significant increase in the prevalence of myopia, the mechanisms underlying the development of myopia and its progression towards retinopathy remain unknown [3], with no early diagnostic markers for preventing myopic pathology [1,2].
The development and progression of myopia leads to both structural and functional ocular alterations. Such myopic alterations include decreased blood oxygen supply [5], inner retina, choroid, and scleral thinning [6,7,8,9,10], decreased microvascular density [5,11,12,13,14], and decreased retinal pigment epithelium density [15,16]. Some of our previous work has described a decrease in astrocyte density along with an increase in glial fibrillary acidic protein (GFAP) spatial coverage associated with thinner retinal nerve fiber layer (RNFL) thickness [17], and decreased peripapillary retinal ganglion cell density [18] in marmosets (Callithrix jacchus), a well-established non-human primate model of myopia [19], that were induced with myopia for 4 months and was exacerbated in marmosets induced with myopia for ten months [20]. We have also identified an increase in central and peripheral retinal string vessel density and vascular branchpoint density in eyes induced with myopia for 4 and 10 months [21]. In addition, increased GFAP expression from astrocytes and Müller cells has recently been identified in a mouse model of myopia [22].
Retinal ganglion cells (RGCs) are projection neurons of the vertebrate retina that convey information from other retinal neurons to visual centers in the brain [23,24]. They have a very high metabolism [25] and require the optimal provision of oxygen and nutrients to sustain activity [26]. The special structural architecture of RGCs allows them to be multipotent, with long projecting axons, synaptic terminals to the brain, and elaborate dendritic projection patterns within the retina [27,28]. Under metabolic stress, RGCs are particularly vulnerable to degeneration [29], particularly when coupled with vascular [30,31] and glial dysregulation [32,33,34], which can result in severe retinal neuropathies. This has been demonstrated in both human and experimental models of diseases, including diabetes [35,36,37], glaucoma [26,38,39,40,41], and ocular ischemia [42,43,44,45]. Loss of RGCs within the GCL layer also occurs with age [46,47,48], along with a dendritic reorganization during normal aging [49]. Myopia has been associated with inner and outer retinal thinning [6,50,51,52,53] and increased vascular [16,21,54,55] and glial alterations [17,22,56], which is consistent with other diseases demonstrating similar features occurring parallel to the presence of RGC alterations, dysfunction, or degeneration.
The photopic negative response (PhNR) is the negative wave of the electroretinogram (ERG) immediately following the b-wave, and is indicative of RGC and glial cell function [57] in human [58,59,60] and non-human primate models [61,62]. The PhNR amplitude is used to monitor retinal health in diseases, such as diabetic retinopathy [63], glaucoma [57,64], and retinal ischemic disorders [65], and it corresponds well to inner retinal dysfunction [61]. RGCs contribute the most to the PhNR [59,66,67], making the PhNR a sensitive marker of retinal ganglion cell dysfunction that is highly characteristic of glaucoma [58,61,67,68]. Both myopia and glaucoma are known to cause changes to the inner retinal structure [6,17,50,69,70,71,72,73] and function [8,74,75,76,77]. Full-field ERGs are also known to change with any increase in the axial length of myopic human eyes, especially in eyes with axial lengths greater than 28.00 mm [78]. Axial length is also known to be a greater determinant for full-field ERG responses than refractive error or retinal thickness [78,79].
Our laboratory has reported reduced peripapillary RGC density associated with increasing degrees of myopia and axial lengths in marmosets that were induced with myopia for four months [18] and alterations to inner retinal saturated amplitudes in myopic marmosets that were induced for 4 months compared to controls [80]. However, myopia’s longitudinal effects on RGC density and function, and how they change with increased durations of myopic treatment remains unknown. Here, we aim to describe changes to retinal ganglion cell density and function in marmosets induced with sustained myopia for two periods of time (4 vs. 10 months) to assess the effect of progressive myopic growth on the RGC template, which remains unknown. The results reveal a pan-retinal decrease in retinal ganglion cell density in animals induced with myopia for 4 months that became exacerbated in the peripapillary region of marmosets induced with myopia for 10 months, along with alterations to the photopic negative response (PhNR), both of which are hallmarks of neurodegenerative retinal change.

2. Results

The age, refractive error, and axial length of all marmoset eyes included in the four treatment groups can be found in Table 1. Magnification correction using a tangential equation was performed to account for the effect that the increased myopic eye size may have on the RGC quantifications. Retinal ganglion cells were located in the ganglion cell layer of both control and myopic marmosets; no displaced ganglion cells were found in other retinal layers. By modeling the expected redistribution of RGCs along the increased surface area, we found a difference of 7% between the predicted number of RGCs (higher) and the actual number of RGCs (lower), which is statistically insignificant and may point to myopic RGC redistribution as the pre-eminent reason for the myopic decline in RGC density noted in this study. A representative image of a complete marmoset retina’s superficial vasculature and areas where the retinas were imaged and quantified can be seen in Figure 1A (modified from Lin et al., 2022 [17]). The location of the parafoveal (Pf), peripapillary (Pp), and peripheral (Ph) retina are shown in Figure 1B.

2.1. Parafoveal Ganglion Cell Density Is Lower in Marmosets Induced with Myopia for 4 and 10 Months Compared to Age-Matched Controls

Representative images of parafoveal ganglion cells stained with BRN3A can be seen in Figure 2A. The parafoveal ganglion cell density remained unchanged in controls as they grew (6 vs. 12-month-old control eyes, p > 0.05) but was significantly lower in the parafoveal retina of myopic marmosets induced with myopia for 4 months (Figure 2B, p < 0.05) and remained decreased after 10 months of induced myopia compared to controls (Figure 2B, p < 0.01).

2.2. Peripapillary Ganglion Cell Density Is Lower in Marmosets Induced with Myopia for 10 Months vs. 4 Months

Representative images of peripapillary ganglion cells stained with BRN3A are shown in Figure 3A. The peripapillary ganglion cell density remained unchanged in controls as they grew (6 vs. 12-month-old control eyes, p > 0.05), but was significantly lower in the peripapillary retina of marmosets induced with myopia for 4 months (Figure 3B, p < 0.05). The peripapillary decrease in RGC density was greater in marmosets that experienced sustained myopia for 10 months compared to 4 months (Figure 3B, p < 0.05). The myopic peripapillary region was the area that exhibited the greatest percent decrease in RGC density (30–40%) compared to age-matched controls, and compared to the myopic parafoveal (20–30%) and peripheral (20–30%) regions.

2.3. Peripheral Ganglion Cell Density Is Lower in Marmosets Induced with Myopia for 4 and 10 Months Compared to Age-Matched Controls

Representative images of peripheral ganglion cells stained with BRN3A are shown in Figure 4A. Ganglion cell density decreased from the center to the peripheral retina in all treatment groups (Figure 2B, Figure 3B and Figure 4B). The peripapillary ganglion cell density remained unchanged in the controls as they grew (6 vs. 12-month-old control eyes, p > 0.05). but was significantly lower in the periphery of myopic marmosets after 4 months (Figure 4B, p < 0.05) and 10 months of treatment (Figure 4B, p < 0.01). Sustained myopia did not lead to greater changes in peripheral ganglion cell density in myopic animals treated for 4 vs. 10 months (p > 0.05).

2.4. Dampening of PhNR Amplitude Occurs in Eyes Induced with Myopia for 10 but Not 4 Months

The PhNR Vmax amplitude differed across all groups in this study, with marmosets induced with myopia for 10 months (red) experiencing the greatest decrease in PhNR amplitude (Figure 5A, p < 0.05). The PhNR Vmax amplitude in myopic marmosets induced for 10 months (red) was significantly decreased compared to their age-matched controls (Figure 5B, p < 0.01). Myopic eyes induced for 10 months exhibited a significantly decreased PhNR Vmax compared to myopic eyes induced for 4 months (p < 0.05). An increased axial length was significantly associated with a decreased PhNR Vmax amplitude in myopic eyes induced for 10 months (R2 = 0.98, p < 0.05) but not for 4 months (R2 = 0.33, p = 0.46). The decreased PhNR amplitude in myopic eyes induced for 10 months was also significantly associated with both decreased parafoveal (R2 = 0.78, p < 0.05) and decreased peripapillary RGC density (R2 = 0.71, p < 0.05).

3. Discussion

This study provides evidence that sustained exposure to negative defocus and myopia development alters ganglion cell density and retinal activity in an established non-human primate model of lens-induced myopia. Compared to age-matched controls, marmoset eyes induced with myopia for four months exhibited a pan-retinal decreased ganglion cell density that became exacerbated in the peripapillary region and was accompanied by a dampened PhNR amplitude in eyes induced with myopia for 10 months.
Ganglion cells are crucial for vision and information transmission [84,85,86,87], especially for central vision in species with foveated retinas, and have been extensively studied in monkeys [88,89,90,91], mice [92,93,94,95,96], cats [97,98,99,100], and humans [46,101,102]. RGCs project their axons along the optic nerve, propagating visual stimuli from the retina to the brain [103]. They are major output cells that process and convey information [104], and comprise subpopulations each with distinct structures and functions [105,106]. RGCs show different levels of contrast sensitivity, visual acuity, and color coding, and a close correlation exists between RGC function and their structural morphology [107,108,109,110,111]. The highest ganglion cell density in primates and humans occurs 0.4–2.0 mm from the foveal center (around 32,000–38,000 cells/mm2 in normal young human retinas), and decreases in a horizontally oriented elliptical shape towards the periphery [101]. When the retina’s structural integrity is affected in disease, RGC density and distribution can also be affected and can alter normal vision and physiology. We hypothesize that ganglion cell density, distribution, and function are affected during myopia development and progression.

3.1. Pan-Retinal Ganglion Cell Density Decreases in Marmoset Eyes Induced with Myopia for 4 and 10 Months

Retinal ganglion cells can be labeled via a few different markers, including tubulin beta-3 chain (TUBB3) [112], brain-specific homeobox/POU domain protein 3A (BRN3A) [113], and RNA binding protein with multiple splicing (RBPMS) [114]. The Brn3A antibody is a reliable marker to identify RGC nuclei and quantify RGCs in both naïve and damaged retinas [113,115], and is known to label predominantly vision-forming RGCs [116]. Marmoset eyes induced with myopia continuously for 4 or 10 months exhibited a similar decrease in BRN3A+ retinal ganglion cell density compared to age-matched controls, which remained significant after correcting for the effect of myopic magnification. Lower RGC cell counts along with thinner inner retinal thicknesses and decreased visual field sensitivity have been observed in macaques with induced glaucoma [73]. However, specific information describing myopic RGC numbers and function remains to be determined, making direct measurements of RGCs and RGC density in experimental myopia crucial to understanding the sequence of events taking place prior to the development of myopic retinopathy, as well as the etiology of myopic visual decline.
The eyes of untreated controls aged 6 and 12 months exhibited similar ganglion cell densities across the retina and the densities aligned with those reported in older marmosets [117], as well as with studies from our laboratory [18]. RGC density in animals induced with experimental myopia, however, decreased by approximately 30% in all retinal areas studied (parafovea, peripapillary, and periphery). Eyes induced with myopia for 10 months experienced greater decreases in RGC density in the peripapillary region, compared to myopic eyes induced with myopia for 4 months. The peripapillary region of myopic eyes treated for 4 and 10 months with negative lens wear experienced exacerbated decreases in RGC density. We hypothesize that this decrease in RGC density may be due to ganglion cell redistribution from extrinsic factors, such as increased myopic growth and mechanical stress. Susceptible areas for the effects of ocular mechanical stress include the lamina cribrosa and the peripapillary sclera [118,119,120], which are both known to be altered in myopia progression [52,121,122] and are directly adjacent to the peripapillary retina measured in the marmosets of this study. This is of particular importance because the peripapillary retina is the main region where the decrease in RGC density was greater in the study marmosets treated for 10 months versus those treated for 4 months. The peripheral RGC densities did not worsen with prolonged myopia despite axial elongation. This could be due to the majority of retinal ganglion cells being located in the posterior pole [70], leading to peripapillary RGCs being the most affected with sustained myopia.
Myopic growth is known to be non-uniform, via posterior/axial expansion [123,124] and sagittal enlargement in the equatorial region [15]. While the specific locations where the retinas in this study experience greater elongation and/or expansion are unknown, larger eyes normally contain a greater retinal surface area subtending a given visuospatial field [125]. Myopic stretch could cause the same number of RGCs to have spread over a larger surface area, resulting in less densely packed ganglion cells [69] (observed in this study) or larger cell bodies (not observed in this study). The myopic marmoset retinas in our study exhibited a 10% increase in surface area compared to age-matched controls. In the literature, chicks induced with form-deprivation myopia exhibit reduced RGC cell density (greater in the peripheral versus the mid-peripheral retina) compared to control eyes [126], sampled every 2.5 mm along the horizontal and 0.6 mm along the vertical meridians of whole retinal flat mounts. Additionally, these myopic chick eyes exhibited greater RGC dendritic arborization [126]. This decreased ganglion cell density with compensatory increased arborization could explain why chick myopic eyes have been described to have poorer visual function, though this was not studied in the present work. Decreased ganglion cell density and thickness have also been identified in human myopic eyes [125], although the density calculations were not performed using histology but ganglion cell layer tissue volume. A histological study of human eyes found that within the central and peripheral nervous system, a relationship exists between cell numbers, size, and density [127,128], meaning the larger the organ, the larger the soma size of the cells within the organ, and the less densely packed the cells. As presented, myopia appears to manifest with decreased ganglion cell densities across species, and the implications of decreased RGC density on long-term healthy vision need more investigation in the future.
The hallmark disease exhibiting a decrease in ganglion cell counts is glaucoma, which causes RGCs to become damaged and undergo cell apoptosis leading to death at severe stages [129,130,131,132,133]. RGCs are inherently mechanosensitive cells [134,135,136], and any extended duration of biomechanical stressors (like myopic eye growth) can potentiate the development and progression of RGC dysfunction.
A possible confounding variable in the RGC density changes noted could be interanimal variability. However, the greater drop in peripapillary RGC density observed in marmosets induced with myopia for 10 months vs. 4 months might also be due to the known effect that aging has on retinal ganglion cell function, in particular the age-related losses of neurons in the inner retina [137]. This may also explain why age is a significant risk factor for the development of vision defects. With age, the risk of both pathological and non-pathological RGC loss occurrence increases [137,138]. The locational patterns and the extent of age-related neuronal loss are known to be different in control and glaucomatous mice retinas, with control eyes showing diffuse RGC loss occurring at a greater intensity after 12 months of age and glaucomatous eyes showing patchy, non-quadrant-preferential RGC loss occurring steadily over time and slowing down after 15 months of age [139]. Another study of mouse RGCs showed decreasing RGC dendritic arborization and a minimal decline in RGC numbers with age [140]. Not all mammals experience the same effects of aging on RGC density. Human studies have shown an age-related histological loss of RGCs with no preference for the size or type of RGC [46,137], which presents with concurrent thinning of retinal nerve fiber layers [50,137]. Findings from rhesus monkeys [141] and quoka wallabys [142] have shown no change in RGC numbers with age. The first changes from aging that occur in a monkey brain are visual cortex myelin and glial cell degeneration [143,144,145,146], followed by a decrease in visual cortex ganglion cell density. This is similar to the sequence of events seen with physiological aging in the retina, beginning with retinal glial changes during early aging [147,148], and followed by retinal ganglion cell structural abnormalities and functional deficits with time [46,149]. However, it is important to highlight that there was no age-related ganglion cell loss seen in our control marmoset eyes. Greater periods of study may be necessary to understand the effects of age on ganglion cells in marmoset retinas.

3.2. Photopic Negative Response (PhNR) Amplitude Is Significantly Dampened in Marmosets Induced with Myopia for 10 Months, but Not in Marmosets Treated for 4 Months

Electroretinography (ERG) is crucial for evaluating retinal function and assessing the electrical potentials from retinal cells to light stimulation [63]. The Photopic Negative Response (PhNR) is the negative potential following the b-wave that originates from retinal ganglion cells (RGCs) and glial cells, corresponding to inner retinal function. The PhNR in particular is useful for detecting early glaucoma and evaluating the retinal function of patients with retinal ischemic disorders [58,60,61,68,150], and corresponds with the amount of inner retina dysfunction [61].
Myopic marmosets treated for 10 months exhibited a dampening of the PhNR amplitude compared to their age-matched controls. These changes were not observed in marmosets induced with myopia for 4 months. The PhNR amplitude is the negative response of the photopic electroretinogram (ERG), and is indicative of inner retinal cone-related RGC and glial cell function [57]. Amacrine cells have also been shown to contribute to the PhNR amplitude by modulating information between RGCs and bipolar cells [61]. The full-field PhNR amplitude is also associated with the mean deviation of visual fields and retinal nerve fiber layer thickness [151]. In human studies [57,64] of sustained IOP elevations and subsequent reductions in IOP, the PhNR amplitude decreases then increases, with residual slower implicit times that are likely due to these processes being glial cell-mediated [61]. Improved glial function is proposed to be one mechanism by which PhNR amplitude shows improvements following IOP reductions, possibly via more effective ion homeostatic control; however, the major component of the PhNR is likely from RGCs [57]. The P1 and N1 amplitudes (the two components of the PhNR) have been shown to be lower in human myopic eyes [78,152], with no alteration in implicit times [153,154]. Full-field ERGs are known to change with any increase in the axial length of myopic human eyes, especially in eyes with axial lengths greater than 28.00 mm [78]. Axial length is also known to be a greater determinant for full-field ERG responses than either refractive error or retinal thickness [78,79]. To our knowledge, our laboratory is among the first to specifically study the PhNR in an experimental model of sustained myopia; most studies to date have only provided evidence of reduced electroretinogram function, with no specific mention of PhNR amplitudes. A recent study from our laboratory investigating the ERG function of marmosets over a range of ages has shown alterations to inner retinal saturated amplitudes in myopic marmosets compared to controls [80], similar to findings in this study’s marmosets.
A decreased PhNR amplitude is associated with both decreased parafoveal and peripapillary RGC densities, as well as increasing axial lengths, in myopic marmosets treated for 10 months. The axial elongation of myopic eyes can cause inner retinal stretch and subsequently, a reduced sampling density of retinal neurons and their functional physiology [155]. Myopic eyes experience asymmetric stretch, with both peripheral and macular pathologies often occurring in degenerative myopia [13]. We postulate that sustained myopic retinal stretch, known to cause cellular redistribution and morphological changes, is likely to cause functional alterations as seen in the decrease in PhNR amplitudes seen only in myopic marmoset eyes that were treated with negative lens wear for 10 months (but not exhibited in myopic eyes that were treated for 4 months). Myopic marmosets treated for four months may not have experienced a long enough exposure to negative defocus to warrant significant associations between RGC density and axial length and retinal physiology in the peripheral region, but have been shown to experience a non-significant trend towards PhNR dampening [80,156].
The PhNR amplitude alteration noted with electroretinography in the older myopic marmosets points to possible functional alterations of the photoreceptors, glial cells, and ganglion cells occurring in the absence of stark myopic pathology. Understanding the longitudinal effect of progressive experimental myopia on retinal cellular structures in tandem with retinal circuitry is critical for managing the conversion from high to pathological myopia. Considering ocular axial length may also serve to be useful in predicting the severity of the functional alterations in retinal ganglion cells in early myopic degeneration.

4. Materials and Methods

4.1. Marmoset Model of Myopia

Twelve marmoset eyes were studied and randomly grouped into treated or age-matched untreated controls: three 6-month-old myopic eyes (6 m Myope) were induced with myopia for 4 months (from 2 to 6 months of age), three age-matched 6-month-old untreated controls (6 m Control), three 12-month-old myopes induced with myopia for 10 months (12 m Myope) from 2 to 12 months of age, and three age-matched 12-month-old controls (12 m Control) (Table 1). Animals were induced with myopia using full-field negative single-vision soft contact lenses (either −5D or −10D) [17]. Statistical power analysis using published data from our laboratory indicates that 3 animals per experimental group provide 80% power for our statistical analysis (n = 3 younger control, n = 3 younger myope, n = 3 older control, n = 3 older myope) [17]. There were no exclusions of animals, experimental units, or data points reported. All animal care, treatment, and experimental protocols were approved by the SUNY College of Optometry Institutional Animal Care and Use Committee (IACUC), and performed as recommended by the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, the US National Research Council’s Guide for the Care and Use of Laboratory Animals, the US Public Health Service’s Policy on Humane Care and Use of Laboratory Animals, and the Guide for the Care and Use of Laboratory animals.
At baseline and end of treatment, cycloplegic refractive error (Rx) and ocular axial length (AL) were measured using the Nidek ARK-900 autorefractor (Nidek Co., LTD, Gamagori, Japan) and an ultrasound biometer (A-scan ultrasound 25 MHz, Panametrics, NDT Ltd., Waltham, MA, USA) respectively, prior to tissue collection under anesthesia (alphaxalone, 15 mg/kg, intramuscular, Zoetis, Parsippany, NJ, USA).

4.2. Electroretinograms (ERGs)

ERG measurements were performed on all marmosets at end of treatment. Marmoset ERGs were recorded using the Espion electrodiagnostic system (Diagnosys LLC, Lowell, MA, USA), consisting of the Espion Ganzfeld ColorDome and its accompanying computer program. The photopic ERG protocol used in this study was the brief 75 (13 steps, 0.00625–26.624 (cd*s)/m2) consisting of increasing flash intensities over 13 steps. The stimulus was a 4-millisecond-long white stimulus presented on a constant white background.
Marmosets were dilated with cyclopentolate hydrochloride (Alcon, Inc. Fort Worth, TX, USA) 1 h prior to measurements, and injected with glycopyrrolate (0.01 mg/kg, IM) and acepromazine (2.5 mg/kg, IM) 25 min prior to ketamine injection. Ketamine (50 mg/kg, IM) was subsequently administered and placed on a warm heating pad after confirming adequate and safe anesthesia, with vitals monitored every 15 min throughout ERG recordings duration. For protecting corneal health, 1% proparacaine hydrochloride (Akorn Inc., Lake Forest, IL, USA) was instilled in both eyes, gold wire electrodes were placed on both corneas, and a black light-proof cloth was placed over the reference eye. A grounding electrode was inserted subcutaneously into the back, and ERG recordings were gathered. At the conclusion of the ERG recording, topical erythromycin ophthalmic ointment was applied to marmoset eyes and marmosets were monitored until full recovery from anesthesia.
The Photopic Negative Response (PhNR) amplitudes were measured at all steps. The PhNR reflects the functioning of ganglion and glial cell responses, and is defined as the negative trough located between the b-wave and d-wave, usually found at around 65 milliseconds. Implicit times for all flash intensities and stimulus parameters were recorded, and response data was fit to a Naka–Rushton equation (below) for plotting intensity–response data [157], as successfully used in previous marmoset experiments in our laboratory [80,156]:
V I = V m a x I n I n + K n
Variables: I stands for the stimulus intensity, V stands for the amplitude at intensity I, Vmax stands for the saturated amplitude, K stands for the semi-saturation constant (stimulus intensity at which half of the saturated amplitude is reached), and n stands for the slope of the function.

4.3. Tissue Collection

At the end of treatment, eyes were enucleated and placed in phosphate-buffered saline (PBS; ThermoFisher, Waltham, MA, USA). Dissected retinas were fixed in Paraformaldehyde (PFA) 4% (Santa Cruz Biotechnology, Dallas, TX, USA) in PBS for 30 min, washed five times for 30 min each with PBS, and incubated with 5% normal donkey serum (Sigma Aldrich, St. Louis, MO, USA), PBS, and 0.5% Triton X (Sigma Aldrich, St. Louis, MO, USA) blocking buffer for one hour to avoid non-specific antibody binding. Following blocking, retinal tissue was incubated with primary antibodies diluted in blocking buffer at 4 °C for 4 days. The antibody used in this study was goat Brain-Specific Homeobox/POU Domain Protein 3A (BRN3A) (1:500, Catalog #sc-39184, Santa Cruz Biotechnology, Dallas, TX, USA) to stain all marmoset retinas. After the primary antibody incubation period, the retinas were washed six times for 10 min each with PBS and incubated with donkey-anti goat secondary antibody conjugated with Alexa 594 (1:200, ThermoFisher, Catalog #A11058, Waltham, MA, USA) for 2 days. Retinal tissues were then washed one time for 30 min, and 6 times for 10 min each with PBS. Retinas were inspected for signs of debris, and consistent tissue thickness was achieved by removing vitreous prior to plating onto SuperFrost slides (ThermoFisher, Waltham, MA, USA). Cover slips were then placed on objectives with DAPI mounting medium (SKU: H-1200-10, Vector Laboratories, Newark, CA, USA), permitted to self-seal, and stored at −20 °C.

4.4. Confocal Microscopy and Image Acquisition

Immunohistochemical samples were imaged using Olympus FV1200 MPE confocal microscope (Olympus Corporation, Tokyo, Japan). The images were gathered, and analyses were performed in a randomized order by one blind investigator (CL). After enucleation, right and left eyes were kept separately, and denotation of the temporal region was marked by the presence of the foveal pit. Twelve images (317 μm × 317 μm along the horizontal plane, and 20 μm along the vertical plane) were taken from each of the twelve retinas imaged. Multiplane z-series were collected using the 40× objective, with each section spaced 1 μm apart. These 20 sections were processed by the confocal microscope to form single z-stacks of images subtending the desired portion of the specimen. Images were processed using Fiji software version 2.9.0. Ganglion cell density (RGC nuclei/mm2) was assessed by imaging all four retinal quadrants (temporal, nasal, superior, and inferior) in the periphery, peripapillary, and parafoveal retina. Temporal region was determined based on the location of the fovea. Nasal region is directly opposite of the temporal region, and depending on the eye, superior and inferior retina were categorized. This regional analysis was performed with the goal of identifying local changes that might occur in myopic eyes due to their asymmetric eye growth pattern.

4.5. Image and Statistical Analysis

Retinal ganglion cell density was calculated as the number of ganglion cell nuclei in every image frame using the Fiji cell counter function and converted to ganglion cells/mm2. A correction for magnification along the two-dimensional plane was performed to account for myopic retinal growth using a tangential equation. Data were assessed for normality and analyzed using student t-test and one-way analysis of variance (ANOVA), and post-hoc analysis with Tukey tests at the level of α = 0.05 was used to examine the differences between treatment and control groups. Pearson’s linear correlation was used to explore the relationship between effective age, axial length, refractive error, and astrocyte measurements. Figures were made using OriginPro 2024b software (OriginLab, Northampton, MA, USA) and were assembled in Adobe InDesign (Adobe, San Jose, CA, USA). An algebraic analysis was also performed to account for increased surface area from myopia, assuming that non-myopic marmosets have spherically shaped eyes and that myopic marmosets have more ellipsoid eyes.

5. Conclusions

Taken together, the pan-retinal decreased ganglion cell density and dampening of the PhNR amplitude observed in myopic marmosets experiencing sustained myopic growth for 4 months suggest that both structural and functional changes are taking place in the ganglion cell template in the absence of myopic pathology. Myopic marmosets treated for 10 months with negative lens wear experienced exacerbated decreased peripapillary ganglion cell density and similarly decreased parafoveal and peripheral ganglion cell density compared to myopic eyes treated for 4 months with lens wear, as well as to their age-matched controls. We hypothesize that a redistribution of the ganglion cell template is occurring during myopia development and progression in this non-human primate model, leading to lower ganglion cell density and PhNR amplitudes, which in turn may represent early signs of anatomical and physiological changes in myopic eyes. The amount of harm incurred by these changes, and whether or not function continues to diminish with myopia progression remains to be seen. Future studies will aim to evaluate quantitatively the changes that occur with older, more myopic eyes.

Author Contributions

Conceptualization, C.R.L. and A.B.-P.; Data curation, C.R.L. and A.B.-P.; Formal analysis, C.R.L.; Funding acquisition, C.R.L. and A.B.-P.; Investigation, C.R.L.; Methodology, C.R.L., R.K.A. and A.B.-P.; Resources, A.B.-P.; Software, C.R.L. and R.K.A.; Supervision, C.R.L. and A.B.-P.; Validation, C.R.L.; Visualization, C.R.L. and A.B.-P.; Writing–original draft, C.R.L.; Writing–review and editing, C.R.L. and A.B.-P. All authors have read and agreed to the published version of the manuscript.

Funding

NIH T35 grant to C.R.L., American Academy of Optometry Career Development Award to A.B.-P., NIH R01 EY034086 to A.B.-P., and NIH K08 EY034545 to C.R.L.

Institutional Review Board Statement

This animal study protocol was approved by the IACUC Ethics Committee of SUNY College of Optometry (protocol code AB2022-06-1, date of approval 24 June 2022).

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Acknowledgments

Sandeep Kumar, Miduturu Srinivas, and Stewart Bloomfield for their advice on immunohistochemical techniques; Andrew Koo for his help in figure conceptualization; Hardy Zhou, Donnicia James, Manish Subedi, and Christina Canellos for their help in treating myopic marmosets; Jibin Zachariah, Bailey Deng, Rossy Angel, Samuel Alphonse, Vanessa Lopez, and Xiomara Santiago for their attention and care to the marmosets included in our study.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Saw, S.M.; Gazzard, G.; Shih-Yen, E.C.; Chua, W.H. Myopia and associated pathological complications. Ophthalmic Physiol. Opt. 2005, 25, 381–391. [Google Scholar] [CrossRef] [PubMed]
  2. Curtin, B.J. The Myopias: Basic Science and Clinical Management; Harper & Row: Philadelphia, PA, USA, 1985; p. xv. 495p. [Google Scholar]
  3. Holden, B.A.; Fricke, T.R.; Wilson, D.A.; Jong, M.; Naidoo, K.S.; Sankaridurg, P.; Wong, T.Y.; Naduvilath, T.J.; Resnikoff, S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 2016, 123, 1036–1042. [Google Scholar] [CrossRef] [PubMed]
  4. Flitcroft, D.I.; He, M.; Jonas, J.B.; Jong, M.; Naidoo, K.; Ohno-Matsui, K.; Rahi, J.; Resnikoff, S.; Vitale, S.; Yannuzzi, L. IMI—Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Investig. Ophthalmol. Vis. Sci. 2019, 60, M20–M30. [Google Scholar] [CrossRef]
  5. Benavente-Perez, A.; Hosking, S.L.; Logan, N.S.; Broadway, D.C. Ocular blood flow measurements in healthy human myopic eyes. Graefes Arch. Clin. Exp. Ophthalmol. 2010, 248, 1587–1594. [Google Scholar] [CrossRef] [PubMed]
  6. Abbott, C.J.; Grunert, U.; Pianta, M.J.; McBrien, N.A. Retinal thinning in tree shrews with induced high myopia: Optical coherence tomography and histological assessment. Vis. Res. 2011, 51, 376–385. [Google Scholar] [CrossRef]
  7. El-Shazly, A.A.; Farweez, Y.A.; ElSebaay, M.E.; El-Zawahry, W.M.A. Correlation between choroidal thickness and degree of myopia assessed with enhanced depth imaging optical coherence tomography. Eur. J. Ophthalmol. 2017, 27, 577–584. [Google Scholar] [CrossRef]
  8. Ismael, Z.F.; El-Shazly, A.A.E.; Farweez, Y.A.; Osman, M.M.M. Relationship between functional and structural retinal changes in myopic eyes. Clin. Exp. Optom. 2017, 100, 695–703. [Google Scholar] [CrossRef]
  9. McBrien, N.A.; Cornell, L.M.; Gentle, A. Structural and ultrastructural changes to the sclera in a mammalian model of high myopia. Investig. Ophthalmol. Vis. Sci. 2001, 42, 2179–2187. [Google Scholar]
  10. Shaikh, A.W.; Siegwart, J.T., Jr.; Norton, T.T. Effect of interrupted lens wear on compensation for a minus lens in tree shrews. Optom. Vis. Sci. 1999, 76, 308–315. [Google Scholar] [CrossRef]
  11. Cheng, D.; Chen, Q.; Wu, Y.; Yu, X.; Shen, M.; Zhuang, X.; Tian, Z.; Yang, Y.; Wang, J.; Lu, F.; et al. Deep perifoveal vessel density as an indicator of capillary loss in high myopia. Eye 2019, 33, 1961–1968. [Google Scholar] [CrossRef]
  12. Fan, H.; Chen, H.Y.; Ma, H.J.; Chang, Z.; Yin, H.Q.; Ng, D.S.; Cheung, C.Y.; Hu, S.; Xiang, X.; Tang, S.B.; et al. Reduced Macular Vascular Density in Myopic Eyes. Chin. Med. J. 2017, 130, 445–451. [Google Scholar] [CrossRef] [PubMed]
  13. Grossniklaus, H.E.; Green, W.R. Pathologic findings in pathologic myopia. Retina 1992, 12, 127–133. [Google Scholar] [CrossRef] [PubMed]
  14. He, J.; Chen, Q.; Yin, Y.; Zhou, H.; Fan, Y.; Zhu, J.; Zou, H.; Xu, X. Association between retinal microvasculature and optic disc alterations in high myopia. Eye 2019, 33, 1494–1503. [Google Scholar] [CrossRef] [PubMed]
  15. Panda-Jonas, S.; Jonas, J.B.; Jonas, R.A. Photoreceptor density in relation to axial length and retinal location in human eyes. Sci. Rep. 2022, 12, 21371. [Google Scholar] [CrossRef]
  16. Su, L.; Ji, Y.S.; Tong, N.; Sarraf, D.; He, X.; Sun, X.; Xu, X.; Sadda, S.R. Quantitative assessment of the retinal microvasculature and choriocapillaris in myopic patients using swept-source optical coherence tomography angiography. Graefes Arch. Clin. Exp. Ophthalmol. 2020, 258, 1173–1180. [Google Scholar] [CrossRef]
  17. Lin, C.; Toychiev, A.; Ablordeppey, R.; Slavi, N.; Srinivas, M.; Benavente-Perez, A. Myopia Alters the Structural Organization of the Retinal Vasculature, GFAP-Positive Glia, and Ganglion Cell Layer Thickness. Int. J. Mol. Sci. 2022, 23, 6202. [Google Scholar] [CrossRef]
  18. Ablordeppey, R.K.; Lin, C.R.; Srinivas, M.; Benavente-Perez, A. Experimental Myopia Results in Peripapillary Ganglion Cell and Astrocyte Reorganization with No Functional Implications During Early Development. Int. J. Mol. Sci. 2024, 25, 13484. [Google Scholar] [CrossRef] [PubMed]
  19. Troilo, D.; Judge, S.J. Ocular development and visual deprivation myopia in the common marmoset (Callithrix jacchus). Vis. Res. 1993, 33, 1311–1324. [Google Scholar] [CrossRef]
  20. Lin, C.R.; Toychiev, A.; Ablordeppey, R.K.; Srinivas, M.; Benavente-Perez, A. Sustained Retinal Defocus Increases the Effect of Induced Myopia on the Retinal Astrocyte Template. Cells 2024, 13, 595. [Google Scholar] [CrossRef]
  21. Lin, C.R.; Toychiev, A.; Ablordeppey, R.K.; Srinivas, M.; Benavente-Perez, A. Age exacerbates the effect of myopia on retinal capillaries and string vessels. Front. Med. 2023, 10, 1112396. [Google Scholar] [CrossRef]
  22. Zhang, X.; Yu, X.; Wen, Y.; Jin, L.; Zhang, L.; Zhu, H.; Zhang, D.; Xie, C.; Guo, D.; Tong, J.; et al. Functions of retinal astrocytes and Muller cells in mammalian myopia. BMC Ophthalmol. 2022, 22, 451. [Google Scholar] [CrossRef]
  23. Sanes, J.R.; Masland, R.H. The types of retinal ganglion cells: Current status and implications for neuronal classification. Annu. Rev. Neurosci. 2015, 38, 221–246. [Google Scholar] [CrossRef] [PubMed]
  24. Sernagor, E.; Eglen, S.J.; Wong, R.O. Development of retinal ganglion cell structure and function. Prog. Retin. Eye Res. 2001, 20, 139–174. [Google Scholar] [CrossRef]
  25. Casson, R.J.; Chidlow, G.; Crowston, J.G.; Williams, P.A.; Wood, J.P.M. Retinal energy metabolism in health and glaucoma. Prog. Retin. Eye Res. 2021, 81, 100881. [Google Scholar] [CrossRef]
  26. Alarcon-Martinez, L.; Shiga, Y.; Villafranca-Baughman, D.; Cueva Vargas, J.L.; Vidal Paredes, I.A.; Quintero, H.; Fortune, B.; Danesh-Meyer, H.; Di Polo, A. Neurovascular dysfunction in glaucoma. Prog. Retin. Eye Res. 2023, 97, 101217. [Google Scholar] [CrossRef]
  27. Almasieh, M.; Wilson, A.M.; Morquette, B.; Cueva Vargas, J.L.; Di Polo, A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 2012, 31, 152–181. [Google Scholar] [CrossRef] [PubMed]
  28. Boal, A.M.; Risner, M.L.; Cooper, M.L.; Wareham, L.K.; Calkins, D.J. Astrocyte Networks as Therapeutic Targets in Glaucomatous Neurodegeneration. Cells 2021, 10, 1368. [Google Scholar] [CrossRef]
  29. Calkins, D.J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin. Eye Res. 2012, 31, 702–719. [Google Scholar] [CrossRef]
  30. Flammer, J.; Haefliger, I.O.; Orgul, S.; Resink, T. Vascular dysregulation: A principal risk factor for glaucomatous damage? J. Glaucoma 1999, 8, 212–219. [Google Scholar]
  31. Mrugacz, M.; Bryl, A.; Zorena, K. Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients. J. Clin. Med. 2021, 10, 458. [Google Scholar] [CrossRef]
  32. Tezel, G.; Chauhan, B.C.; LeBlanc, R.P.; Wax, M.B. Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Investig. Ophthalmol. Vis. Sci. 2003, 44, 3025–3033. [Google Scholar] [CrossRef]
  33. Kashiwagi, K.; Iizuka, Y.; Araie, M.; Suzuki, Y.; Tsukahara, S. Effects of retinal glial cells on isolated rat retinal ganglion cells. Investig. Ophthalmol. Vis. Sci. 2001, 42, 2686–2694. [Google Scholar]
  34. Coorey, N.J.; Shen, W.; Chung, S.H.; Zhu, L.; Gillies, M.C. The role of glia in retinal vascular disease. Clin. Exp. Optom. 2012, 95, 266–281. [Google Scholar] [CrossRef] [PubMed]
  35. Kern, T.S.; Barber, A.J. Retinal ganglion cells in diabetes. J. Physiol. 2008, 586, 4401–4408. [Google Scholar] [CrossRef]
  36. Potilinski, M.C.; Lorenc, V.; Perisset, S.; Gallo, J.E. Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach. Int. J. Mol. Sci. 2020, 21, 2351. [Google Scholar] [CrossRef]
  37. Simo, R.; Stitt, A.W.; Gardner, T.W. Neurodegeneration in diabetic retinopathy: Does it really matter? Diabetologia 2018, 61, 1902–1912. [Google Scholar] [CrossRef]
  38. Buckley, C.; Hadoke, P.W.; Henry, E.; O’Brien, C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br. J. Ophthalmol. 2002, 86, 227–232. [Google Scholar] [CrossRef]
  39. Flammer, J.; Orgul, S. Optic nerve blood-flow abnormalities in glaucoma. Prog. Retin. Eye Res. 1998, 17, 267–289. [Google Scholar] [CrossRef] [PubMed]
  40. Izzotti, A.; Bagnis, A.; Sacca, S.C. The role of oxidative stress in glaucoma. Mutat. Res. 2006, 612, 105–114. [Google Scholar] [CrossRef]
  41. Resch, H.; Garhofer, G.; Fuchsjager-Mayrl, G.; Hommer, A.; Schmetterer, L. Endothelial dysfunction in glaucoma. Acta Ophthalmol. 2009, 87, 4–12. [Google Scholar] [CrossRef]
  42. Alarcon-Martinez, L.; Villafranca-Baughman, D.; Quintero, H.; Kacerovsky, J.B.; Dotigny, F.; Murai, K.K.; Prat, A.; Drapeau, P.; Di Polo, A. Interpericyte tunnelling nanotubes regulate neurovascular coupling. Nature 2020, 585, 91–95. [Google Scholar] [CrossRef] [PubMed]
  43. Dvoriantchikova, G.; Degterev, A.; Ivanov, D. Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage. Exp. Eye Res. 2014, 123, 1–7. [Google Scholar] [CrossRef] [PubMed]
  44. Lafuente, M.P.; Villegas-Perez, M.P.; Selles-Navarro, I.; Mayor-Torroglosa, S.; Miralles de Imperial, J.; Vidal-Sanz, M. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience 2002, 109, 157–168. [Google Scholar] [CrossRef] [PubMed]
  45. Selles-Navarro, I.; Villegas-Perez, M.P.; Salvador-Silva, M.; Ruiz-Gomez, J.M.; Vidal-Sanz, M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Investig. Ophthalmol. Vis. Sci. 1996, 37, 2002–2014. [Google Scholar]
  46. Harman, A.; Abrahams, B.; Moore, S.; Hoskins, R. Neuronal density in the human retinal ganglion cell layer from 16–77 years. Anat. Rec. 2000, 260, 124–131. [Google Scholar] [CrossRef]
  47. Curcio, C.A.; Drucker, D.N. Retinal ganglion cells in Alzheimer’s disease and aging. Ann. Neurol. 1993, 33, 248–257. [Google Scholar] [CrossRef]
  48. Gao, H.; Hollyfield, J.G. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Investig. Ophthalmol. Vis. Sci. 1992, 33, 1–17. [Google Scholar]
  49. Eliasieh, K.; Liets, L.C.; Chalupa, L.M. Cellular reorganization in the human retina during normal aging. Investig. Ophthalmol. Vis. Sci. 2007, 48, 2824–2830. [Google Scholar] [CrossRef]
  50. Ablordeppey, R.K.; Lin, C.; Benavente-Perez, A. The age-related pattern of inner retinal thickening is affected by myopia development and progression. Sci. Rep. 2022, 12, 22190. [Google Scholar] [CrossRef]
  51. Jonas, J.B.; Jonas, R.A.; Bikbov, M.M.; Wang, Y.X.; Panda-Jonas, S. Myopia: Histology, clinical features, and potential implications for the etiology of axial elongation. Prog. Retin. Eye Res. 2023, 96, 101156. [Google Scholar] [CrossRef]
  52. Jonas, J.B.; Xu, L. Histological changes of high axial myopia. Eye 2014, 28, 113–117. [Google Scholar] [CrossRef]
  53. McBrien, N.A.; Gentle, A. Role of the sclera in the development and pathological complications of myopia. Prog. Retin. Eye Res. 2003, 22, 307–338. [Google Scholar] [CrossRef]
  54. Al-Sheikh, M.; Phasukkijwatana, N.; Dolz-Marco, R.; Rahimi, M.; Iafe, N.A.; Freund, K.B.; Sadda, S.R.; Sarraf, D. Quantitative OCT Angiography of the Retinal Microvasculature and the Choriocapillaris in Myopic Eyes. Investig. Ophthalmol. Vis. Sci. 2017, 58, 2063–2069. [Google Scholar] [CrossRef] [PubMed]
  55. Leng, Y.; Tam, E.K.; Falavarjani, K.G.; Tsui, I. Effect of Age and Myopia on Retinal Microvasculature. Ophthalmic Surg. Lasers Imaging Retin. 2018, 49, 925–931. [Google Scholar] [CrossRef]
  56. Bringmann, A.; Unterlauft, J.D.; Barth, T.; Wiedemann, R.; Rehak, M.; Wiedemann, P. Muller cells and astrocytes in tractional macular disorders. Prog. Retin. Eye Res. 2022, 86, 100977. [Google Scholar] [CrossRef] [PubMed]
  57. Niyadurupola, N.; Luu, C.D.; Nguyen, D.Q.; Geddes, K.; Tan, G.X.; Wong, C.C.; Tran, T.; Coote, M.A.; Crowston, J.G. Intraocular pressure lowering is associated with an increase in the photopic negative response (PhNR) amplitude in glaucoma and ocular hypertensive eyes. Investig. Ophthalmol. Vis. Sci. 2013, 54, 1913–1919. [Google Scholar] [CrossRef] [PubMed]
  58. Colotto, A.; Falsini, B.; Salgarello, T.; Iarossi, G.; Galan, M.E.; Scullica, L. Photopic negative response of the human ERG: Losses associated with glaucomatous damage. Investig. Ophthalmol. Vis. Sci. 2000, 41, 2205–2211. [Google Scholar]
  59. Cvenkel, B.; Sustar, M.; Perovsek, D. Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectral-domain optical coherence tomography. Doc. Ophthalmol. 2017, 135, 17–28. [Google Scholar] [CrossRef]
  60. Machida, S.; Gotoh, Y.; Tanaka, M.; Tazawa, Y. Predominant loss of the photopic negative response in central retinal artery occlusion. Am. J. Ophthalmol. 2004, 137, 938–940. [Google Scholar] [CrossRef]
  61. Viswanathan, S.; Frishman, L.J.; Robson, J.G.; Harwerth, R.S.; Smith, E.L., 3rd. The photopic negative response of the macaque electroretinogram: Reduction by experimental glaucoma. Investig. Ophthalmol. Vis. Sci. 1999, 40, 1124–1136. [Google Scholar]
  62. Kinoshita, J.; Takada, S.; Iwata, N.; Tani, Y. Comparison of photopic negative response (PhNR) between focal macular and full-field electroretinograms in monkeys. Doc. Ophthalmol. 2016, 132, 177–187. [Google Scholar] [CrossRef]
  63. Kim, H.D.; Park, J.Y.; Ohn, Y.H. Clinical applications of photopic negative response (PhNR) for the treatment of glaucoma and diabetic retinopathy. Korean J. Ophthalmol. 2010, 24, 89–95. [Google Scholar] [CrossRef] [PubMed]
  64. North, R.V.; Jones, A.L.; Drasdo, N.; Wild, J.M.; Morgan, J.E. Electrophysiological evidence of early functional damage in glaucoma and ocular hypertension. Investig. Ophthalmol. Vis. Sci. 2010, 51, 1216–1222. [Google Scholar] [CrossRef]
  65. Prencipe, M.; Perossini, T.; Brancoli, G.; Perossini, M. The photopic negative response (PhNR): Measurement approaches and utility in glaucoma. Int. Ophthalmol. 2020, 40, 3565–3576. [Google Scholar]
  66. Kremers, J.; Jertila, M.; Link, B.; Pangeni, G.; Horn, F.K. Spectral characteristics of the PhNR in the full-field flash electroretinogram of normals and glaucoma patients. Doc. Ophthalmol. 2012, 124, 79–90. [Google Scholar] [CrossRef]
  67. Preiser, D.; Lagreze, W.A.; Bach, M.; Poloschek, C.M. Photopic negative response versus pattern electroretinogram in early glaucoma. Investig. Ophthalmol. Vis. Sci. 2013, 54, 1182–1191. [Google Scholar] [CrossRef]
  68. Viswanathan, S.; Frishman, L.J.; Robson, J.G.; Walters, J.W. The photopic negative response of the flash electroretinogram in primary open angle glaucoma. Investig. Ophthalmol. Vis. Sci. 2001, 42, 514–522. [Google Scholar]
  69. Lee, M.W.; Nam, K.Y.; Park, H.J.; Lim, H.B.; Kim, J.Y. Longitudinal changes in the ganglion cell-inner plexiform layer thickness in high myopia: A prospective observational study. Br. J. Ophthalmol. 2020, 104, 604–609. [Google Scholar] [CrossRef]
  70. Seo, S.; Lee, C.E.; Jeong, J.H.; Park, K.H.; Kim, D.M.; Jeoung, J.W. Ganglion cell-inner plexiform layer and retinal nerve fiber layer thickness according to myopia and optic disc area: A quantitative and three-dimensional analysis. BMC Ophthalmol. 2017, 17, 22. [Google Scholar] [CrossRef]
  71. Swiatczak, B.; Feldkaemper, M.; Schraermeyer, U.; Schaeffel, F. Demyelination and shrinkage of axons in the retinal nerve fiber layer in chickens developing deprivation myopia. Exp. Eye Res. 2019, 188, 107783. [Google Scholar] [CrossRef]
  72. Alasil, T.; Wang, K.; Keane, P.A.; Lee, H.; Baniasadi, N.; de Boer, J.F.; Chen, T.C. Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J. Glaucoma 2013, 22, 532–541. [Google Scholar] [CrossRef] [PubMed]
  73. Antwi-Boasiako, K.; Carter-Dawson, L.; Harwerth, R.; Gondo, M.; Patel, N. The Relationship Between Macula Retinal Ganglion Cell Density and Visual Function in the Nonhuman Primate. Investig. Ophthalmol. Vis. Sci. 2021, 62, 5. [Google Scholar] [CrossRef] [PubMed]
  74. Huang, W.; Hu, F.; Wang, M.; Gao, F.; Xu, P.; Xing, C.; Sun, X.; Zhang, S.; Wu, J. Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models. Exp. Eye Res. 2018, 172, 112–122. [Google Scholar] [CrossRef]
  75. Lee, S.; Han, S.X.; Young, M.; Beg, M.F.; Sarunic, M.V.; Mackenzie, P.J. Optic nerve head and peripapillary morphometrics in myopic glaucoma. Investig. Ophthalmol. Vis. Sci. 2014, 55, 4378–4393. [Google Scholar] [CrossRef]
  76. Ho, W.C.; Kee, C.S.; Chan, H.H. Myopic children have central reduction in high contrast multifocal ERG response, while adults have paracentral reduction in low contrast response. Investig. Ophthalmol. Vis. Sci. 2012, 53, 3695–3702. [Google Scholar] [CrossRef]
  77. Luu, C.D.; Lau, A.M.; Koh, A.H.; Tan, D. Multifocal electroretinogram in children on atropine treatment for myopia. Br. J. Ophthalmol. 2005, 89, 151–153. [Google Scholar] [CrossRef]
  78. Sachidanandam, R.; Ravi, P.; Sen, P. Effect of axial length on full-field and multifocal electroretinograms. Clin. Exp. Optom. 2017, 100, 668–675. [Google Scholar] [CrossRef]
  79. Chan, H.L.; Mohidin, N. Variation of multifocal electroretinogram with axial length. Ophthalmic Physiol. Opt. 2003, 23, 133–140. [Google Scholar] [CrossRef]
  80. Ablordeppey, R.K.; Nieu, R.; Lin, C.R.; Benavente-Perez, A. Early Alterations in Inner-Retina Neural and Glial Saturated Responses in Lens-Induced Myopia. Transl. Vis. Sci. Technol. 2024, 13, 16. [Google Scholar] [CrossRef]
  81. Benavente-Perez, A.; Nour, A.; Troilo, D. Axial eye growth and refractive error development can be modified by exposing the peripheral retina to relative myopic or hyperopic defocus. Investig. Ophthalmol. Vis. Sci. 2014, 55, 6765–6773. [Google Scholar] [CrossRef]
  82. Benavente-Perez, A.; Nour, A.; Troilo, D. The effect of simultaneous negative and positive defocus on eye growth and development of refractive state in marmosets. Investig. Ophthalmol. Vis. Sci. 2012, 53, 6479–6487. [Google Scholar] [CrossRef]
  83. Benavente-Perez, A.; Nour, A.; Troilo, D. Short Interruptions of Imposed Hyperopic Defocus Earlier in Treatment are More Effective at Preventing Myopia Development. Sci. Rep. 2019, 9, 11459. [Google Scholar] [CrossRef]
  84. Dorrell, M.I.; Aguilar, E.; Jacobson, R.; Trauger, S.A.; Friedlander, J.; Siuzdak, G.; Friedlander, M. Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia 2010, 58, 43–54. [Google Scholar] [CrossRef] [PubMed]
  85. Dorrell, M.I.; Aguilar, E.; Friedlander, M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Investig. Ophthalmol. Vis. Sci. 2002, 43, 3500–3510. [Google Scholar]
  86. Varela, H.J.; Hernandez, M.R. Astrocyte responses in human optic nerve head with primary open-angle glaucoma. J. Glaucoma 1997, 6, 303–313. [Google Scholar] [PubMed]
  87. Ogden, T.E. Nerve fiber layer astrocytes of the primate retina: Morphology, distribution, and density. Investig. Ophthalmol. Vis. Sci. 1978, 17, 499–510. [Google Scholar]
  88. Ghosh, K.K.; Goodchild, A.K.; Sefton, A.E.; Martin, P.R. Morphology of retinal ganglion cells in a new world monkey, the marmoset Callithrix jacchus. J. Comp. Neurol. 1996, 366, 76–92. [Google Scholar] [CrossRef]
  89. Perry, V.H.; Cowey, A. Retinal ganglion cells that project to the superior colliculus and pretectum in the macaque monkey. Neuroscience 1984, 12, 1125–1137. [Google Scholar] [CrossRef]
  90. Schiller, P.H.; Malpeli, J.G. Properties and tectal projections of monkey retinal ganglion cells. J. Neurophysiol. 1977, 40, 428–445. [Google Scholar] [CrossRef]
  91. Weber, A.J.; Kaufman, P.L.; Hubbard, W.C. Morphology of single ganglion cells in the glaucomatous primate retina. Investig. Ophthalmol. Vis. Sci. 1998, 39, 2304–2320. [Google Scholar]
  92. Baden, T.; Berens, P.; Franke, K.; Roman Roson, M.; Bethge, M.; Euler, T. The functional diversity of retinal ganglion cells in the mouse. Nature 2016, 529, 345–350. [Google Scholar] [CrossRef] [PubMed]
  93. Cooper, M.L.; Crish, S.D.; Inman, D.M.; Horner, P.J.; Calkins, D.J. Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma. Exp. Eye Res. 2016, 150, 22–33. [Google Scholar] [CrossRef]
  94. Pang, I.H.; Clark, A.F. Inducible rodent models of glaucoma. Prog. Retin. Eye Res. 2020, 75, 100799. [Google Scholar] [CrossRef] [PubMed]
  95. Sun, W.; Li, N.; He, S. Large-scale morphological survey of mouse retinal ganglion cells. J. Comp. Neurol. 2002, 451, 115–126. [Google Scholar] [CrossRef]
  96. Williams, R.W.; Strom, R.C.; Rice, D.S.; Goldowitz, D. Genetic and environmental control of variation in retinal ganglion cell number in mice. J. Neurosci. 1996, 16, 7193–7205. [Google Scholar] [CrossRef] [PubMed]
  97. Bouhenni, R.A.; Dunmire, J.; Sewell, A.; Edward, D.P. Animal models of glaucoma. J. Biomed. Biotechnol. 2012, 2012, 692609. [Google Scholar] [CrossRef]
  98. Enroth-Cugell, C.; Goldstick, T.K.; Linsenmeier, R.A. The contrast sensitivity of cat retinal ganglion cells at reduced oxygen tensions. J. Physiol. 1980, 304, 59–81. [Google Scholar] [CrossRef]
  99. Rodieck, R.W.; Stone, J. Analysis of receptive fields of cat retinal ganglion cells. J. Neurophysiol. 1965, 28, 833–849. [Google Scholar] [CrossRef]
  100. Stone, J.; Fukuda, Y. Properties of cat retinal ganglion cells: A comparison of W-cells with X- and Y-cells. J. Neurophysiol. 1974, 37, 722–748. [Google Scholar] [CrossRef]
  101. Curcio, C.A.; Allen, K.A. Topography of ganglion cells in human retina. J. Comp. Neurol. 1990, 300, 5–25. [Google Scholar] [CrossRef]
  102. Reinhard, K.; Munch, T.A. Visual properties of human retinal ganglion cells. PLoS ONE 2021, 16, e0246952. [Google Scholar] [CrossRef] [PubMed]
  103. Mead, B.; Tomarev, S. Evaluating retinal ganglion cell loss and dysfunction. Exp. Eye Res. 2016, 151, 96–106. [Google Scholar] [CrossRef]
  104. Gollisch, T. Throwing a glance at the neural code: Rapid information transmission in the visual system. HFSP J. 2009, 3, 36–46. [Google Scholar] [CrossRef]
  105. Wassle, H.; Boycott, B.B. Functional architecture of the mammalian retina. Physiol. Rev. 1991, 71, 447–480. [Google Scholar] [CrossRef]
  106. Dacey, D.M. Primate retina: Cell types, circuits and color opponency. Prog. Retin. Eye Res. 1999, 18, 737–763. [Google Scholar] [CrossRef] [PubMed]
  107. Amthor, F.R.; Oyster, C.W.; Takahashi, E.S. Morphology of on-off direction-selective ganglion cells in the rabbit retina. Brain Res. 1984, 298, 187–190. [Google Scholar] [CrossRef]
  108. Amthor, F.R.; Takahashi, E.S.; Oyster, C.W. Morphologies of rabbit retinal ganglion cells with concentric receptive fields. J. Comp. Neurol. 1989, 280, 72–96. [Google Scholar] [CrossRef] [PubMed]
  109. Amthor, F.R.; Takahashi, E.S.; Oyster, C.W. Morphologies of rabbit retinal ganglion cells with complex receptive fields. J. Comp. Neurol. 1989, 280, 97–121. [Google Scholar] [CrossRef]
  110. Saito, H.A. Morphology of physiologically identified X-, Y-, and W-type retinal ganglion cells of the cat. J. Comp. Neurol. 1983, 221, 279–288. [Google Scholar] [CrossRef]
  111. Stanford, L.R.; Sherman, S.M. Structure/function relationships of retinal ganglion cells in the cat. Brain Res. 1984, 297, 381–386. [Google Scholar] [CrossRef]
  112. Jiang, S.M.; Zeng, L.P.; Zeng, J.H.; Tang, L.; Chen, X.M.; Wei, X. beta-III-Tubulin: A reliable marker for retinal ganglion cell labeling in experimental models of glaucoma. Int. J. Ophthalmol. 2015, 8, 643–652. [Google Scholar] [CrossRef] [PubMed]
  113. Nadal-Nicolas, F.M.; Jimenez-Lopez, M.; Sobrado-Calvo, P.; Nieto-Lopez, L.; Canovas-Martinez, I.; Salinas-Navarro, M.; Vidal-Sanz, M.; Agudo, M. Brn3a as a marker of retinal ganglion cells: Qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Investig. Ophthalmol. Vis. Sci. 2009, 50, 3860–3868. [Google Scholar] [CrossRef]
  114. Kwong, J.M.; Caprioli, J.; Piri, N. RNA binding protein with multiple splicing: A new marker for retinal ganglion cells. Investig. Ophthalmol. Vis. Sci. 2010, 51, 1052–1058. [Google Scholar] [CrossRef]
  115. Corral-Domenge, C.; de la Villa, P.; Mansilla, A.; Germain, F. Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration. Int. J. Mol. Sci. 2022, 23, 4287. [Google Scholar] [CrossRef]
  116. Nadal-Nicolas, F.M.; Galindo-Romero, C.; Lucas-Ruiz, F.; Marsh-Amstrong, N.; Li, W.; Vidal-Sanz, M.; Agudo-Barriuso, M. Pan-retinal ganglion cell markers in mice, rats, and rhesus macaques. Zool. Res. 2023, 44, 226–248. [Google Scholar] [CrossRef] [PubMed]
  117. Kumar, S.; Benavente-Perez, A.; Ablordeppey, R.; Lin, C.; Viswanathan, S.; Akopian, A.; Bloomfield, S.A. A Robust Microbead Occlusion Model of Glaucoma for the Common Marmoset. Transl. Vis. Sci. Technol. 2022, 11, 14. [Google Scholar] [CrossRef]
  118. Coudrillier, B.; Tian, J.; Alexander, S.; Myers, K.M.; Quigley, H.A.; Nguyen, T.D. Biomechanics of the human posterior sclera: Age- and glaucoma-related changes measured using inflation testing. Investig. Ophthalmol. Vis. Sci. 2012, 53, 1714–1728. [Google Scholar] [CrossRef]
  119. Grytz, R.; Girkin, C.A.; Libertiaux, V.; Downs, J.C. Perspectives on biomechanical growth and remodeling mechanisms in glaucoma. Mech. Res. Commun. 2012, 42, 92–106. [Google Scholar] [CrossRef]
  120. Norman, R.E.; Flanagan, J.G.; Sigal, I.A.; Rausch, S.M.; Tertinegg, I.; Ethier, C.R. Finite element modeling of the human sclera: Influence on optic nerve head biomechanics and connections with glaucoma. Exp. Eye Res. 2011, 93, 4–12. [Google Scholar] [CrossRef]
  121. Jonas, J.B.; Berenshtein, E.; Holbach, L. Lamina cribrosa thickness and spatial relationships between intraocular space and cerebrospinal fluid space in highly myopic eyes. Investig. Ophthalmol. Vis. Sci. 2004, 45, 2660–2665. [Google Scholar] [CrossRef]
  122. Wang, Y.X.; Panda-Jonas, S.; Jonas, J.B. Optic nerve head anatomy in myopia and glaucoma, including parapapillary zones alpha, beta, gamma and delta: Histology and clinical features. Prog. Retin. Eye Res. 2021, 83, 100933. [Google Scholar] [CrossRef] [PubMed]
  123. McMonnies, C.W. Glaucoma history and risk factors. J. Optom. 2017, 10, 71–78. [Google Scholar] [CrossRef] [PubMed]
  124. Matsumura, S.; Kuo, A.N.; Saw, S.M. An Update of Eye Shape and Myopia. Eye Contact Lens 2019, 45, 279–285. [Google Scholar] [CrossRef] [PubMed]
  125. Chen, M.; Nofziger, J.; Datta, R.; Gee, J.C.; Morgan, J.; Aguirre, G.K. The Influence of Axial Length Upon the Retinal Ganglion Cell Layer of the Human Eye. Transl. Vis. Sci. Technol. 2020, 9, 9. [Google Scholar] [CrossRef]
  126. Troilo, D.; Xiong, M.; Crowley, J.C.; Finlay, B.L. Factors controlling the dendritic arborization of retinal ganglion cells. Vis. Neurosci. 1996, 13, 721–733. [Google Scholar] [CrossRef]
  127. Herculano-Houzel, S. Brains matter, bodies maybe not: The case for examining neuron numbers irrespective of body size. Ann. N. Y. Acad. Sci. 2011, 1225, 191–199. [Google Scholar] [CrossRef]
  128. Tower, D.B. Structural and functional organization of mammalian cerebral cortex: The correlation of neurone density with brain size. Cortical neurone density in the fin whale (Balaenoptera physalus L.) with a note on the cortical neurone density in the Indian elephant. J. Comp. Neurol. 1954, 101, 19–51. [Google Scholar] [CrossRef] [PubMed]
  129. Almasieh, M.; Levin, L.A. Neuroprotection in Glaucoma: Animal Models and Clinical Trials. Annu. Rev. Vis. Sci. 2017, 3, 91–120. [Google Scholar] [CrossRef]
  130. Farkas, R.H.; Grosskreutz, C.L. Apoptosis, neuroprotection, and retinal ganglion cell death: An overview. Int. Ophthalmol. Clin. 2001, 41, 111–130. [Google Scholar] [CrossRef]
  131. Garcia-Valenzuela, E.; Gorczyca, W.; Darzynkiewicz, Z.; Sharma, S.C. Apoptosis in adult retinal ganglion cells after axotomy. J. Neurobiol. 1994, 25, 431–438. [Google Scholar] [CrossRef]
  132. Kuehn, M.H.; Fingert, J.H.; Kwon, Y.H. Retinal ganglion cell death in glaucoma: Mechanisms and neuroprotective strategies. Ophthalmol. Clin. N. Am. 2005, 18, 383–395. [Google Scholar] [CrossRef]
  133. Morgan, J.E.; Uchida, H.; Caprioli, J. Retinal ganglion cell death in experimental glaucoma. Br. J. Ophthalmol. 2000, 84, 303–310. [Google Scholar] [CrossRef]
  134. Sigal, I.A.; Ethier, C.R. Biomechanics of the optic nerve head. Exp. Eye Res. 2009, 88, 799–807. [Google Scholar] [CrossRef]
  135. Ingber, D.E. Mechanobiology and diseases of mechanotransduction. Ann. Med. 2003, 35, 564–577. [Google Scholar] [CrossRef] [PubMed]
  136. Tan, J.C.; Kalapesi, F.B.; Coroneo, M.T. Mechanosensitivity and the eye: Cells coping with the pressure. Br. J. Ophthalmol. 2006, 90, 383–388. [Google Scholar] [CrossRef] [PubMed]
  137. Harwerth, R.S.; Wheat, J.L. Modeling the effects of aging on retinal ganglion cell density and nerve fiber layer thickness. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246, 305–314. [Google Scholar] [CrossRef] [PubMed]
  138. Harwerth, R.S.; Smith, E.L., 3rd; DeSantis, L. Experimental glaucoma: Perimetric field defects and intraocular pressure. J. Glaucoma 1997, 6, 390–401. [Google Scholar]
  139. Danias, J.; Lee, K.C.; Zamora, M.F.; Chen, B.; Shen, F.; Filippopoulos, T.; Su, Y.; Goldblum, D.; Podos, S.M.; Mittag, T. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: Comparison with RGC loss in aging C57/BL6 mice. Investig. Ophthalmol. Vis. Sci. 2003, 44, 5151–5162. [Google Scholar] [CrossRef]
  140. Samuel, M.A.; Zhang, Y.; Meister, M.; Sanes, J.R. Age-related alterations in neurons of the mouse retina. J. Neurosci. 2011, 31, 16033–16044. [Google Scholar] [CrossRef]
  141. Kim, C.B.; Tom, B.W.; Spear, P.D. Effects of aging on the densities, numbers, and sizes of retinal ganglion cells in rhesus monkey. Neurobiol. Aging 1996, 17, 431–438. [Google Scholar] [CrossRef]
  142. Harman, A.M.; Moore, S. Number of neurons in the retinal ganglion cell layer of the quokka wallaby do not change throughout life. Anat. Rec. 1999, 256, 78–83. [Google Scholar] [CrossRef]
  143. Peters, A.; Josephson, K.; Vincent, S.L. Effects of aging on the neuroglial cells and pericytes within area 17 of the rhesus monkey cerebral cortex. Anat. Rec. 1991, 229, 384–398. [Google Scholar] [CrossRef] [PubMed]
  144. Peters, A.; Leahu, D.; Moss, M.B.; McNally, K.J. The effects of aging on area 46 of the frontal cortex of the rhesus monkey. Cereb. Cortex 1994, 4, 621–635. [Google Scholar] [CrossRef] [PubMed]
  145. Peters, A.; Rosene, D.L.; Moss, M.B.; Kemper, T.L.; Abraham, C.R.; Tigges, J.; Albert, M.S. Neurobiological bases of age-related cognitive decline in the rhesus monkey. J. Neuropathol. Exp. Neurol. 1996, 55, 861–874. [Google Scholar] [CrossRef] [PubMed]
  146. Peters, A.; Sethares, C. Aging and the Meynert cells in rhesus monkey primary visual cortex. Anat. Rec. 1993, 236, 721–729. [Google Scholar] [CrossRef]
  147. Ramirez, A.I.; Fernandez-Albarral, J.A.; Hoz, R.; Lopez-Cuenca, I.; Salobrar-Garcia, E.; Rojas, P.; Valiente-Soriano, F.J.; Aviles-Trigueros, M.; Villegas-Perez, M.P.; Vidal-Sanz, M.; et al. Microglial changes in the early aging stage in a healthy retina and an experimental glaucoma model. Prog. Brain Res. 2020, 256, 125–149. [Google Scholar] [CrossRef]
  148. Ramirez, J.M.; Ramirez, A.I.; Salazar, J.J.; de Hoz, R.; Trivino, A. Changes of astrocytes in retinal ageing and age-related macular degeneration. Exp. Eye Res. 2001, 73, 601–615. [Google Scholar] [CrossRef]
  149. Harwerth, R.S.; Wheat, J.L.; Rangaswamy, N.V. Age-related losses of retinal ganglion cells and axons. Investig. Ophthalmol. Vis. Sci. 2008, 49, 4437–4443. [Google Scholar] [CrossRef]
  150. Drasdo, N.; Aldebasi, Y.H.; Chiti, Z.; Mortlock, K.E.; Morgan, J.E.; North, R.V. The s-cone PHNR and pattern ERG in primary open angle glaucoma. Investig. Ophthalmol. Vis. Sci. 2001, 42, 1266–1272. [Google Scholar]
  151. Machida, S.; Gotoh, Y.; Toba, Y.; Ohtaki, A.; Kaneko, M.; Kurosaka, D. Correlation between photopic negative response and retinal nerve fiber layer thickness and optic disc topography in glaucomatous eyes. Investig. Ophthalmol. Vis. Sci. 2008, 49, 2201–2207. [Google Scholar] [CrossRef]
  152. Uchida, A. [Studies of electrical activities of the eye in high myopia (author’s transl)]. Nippon. Ganka Gakkai Zasshi 1977, 81, 1328–1350. [Google Scholar] [PubMed]
  153. Chen, J.C.; Brown, B.; Schmid, K.L. Delayed mfERG responses in myopia. Vis. Res. 2006, 46, 1221–1229. [Google Scholar] [CrossRef] [PubMed]
  154. Chen, J.C.; Brown, B.; Schmid, K.L. Retinal adaptation responses revealed by global flash multifocal electroretinogram are dependent on the degree of myopic refractive error. Vis. Res. 2006, 46, 3413–3421. [Google Scholar] [CrossRef] [PubMed]
  155. Chui, T.Y.; Yap, M.K.; Chan, H.H.; Thibos, L.N. Retinal stretching limits peripheral visual acuity in myopia. Vis. Res. 2005, 45, 593–605. [Google Scholar] [CrossRef]
  156. Ablordeppey, R.K.; Lin, C.R.; Song, B.; Benavente-Perez, A. Choroidal Morphology and Photoreceptor Activity Are Related and Affected by Myopia Development. Investig. Ophthalmol. Vis. Sci. 2024, 65, 3. [Google Scholar] [CrossRef]
  157. Severns, M.L.; Johnson, M.A. The care and fitting of Naka-Rushton functions to electroretinographic intensity-response data. Doc. Ophthalmol. 1993, 85, 135–150. [Google Scholar] [CrossRef]
Figure 1. Representative image of whole marmoset retina’s superficial vasculature, demonstrating retinal locations studied. Figure modified from Lin et al. [17]. (A) Control marmoset’s superficial vasculature within whole retina, visualized with Isolectin (green; ID: C16 Left eye; scale bar 1000 μm) and consisting of multiple 4× magnification images stitched together using Photoshop. During analysis, the eye was split into four quadrants: Temporal (outlined in blue, also quadrant where the fovea can be found (yellow circle)), Nasal (directly across the optic nerve from temporal quadrant), Superior, and Inferior quadrants. Each quadrant was further split into peripapillary (Pp) and peripheral (Ph) retinal regions. White boxes labeled 1 to 6 show that six focal areas of 40× magnification exist from optic nerve head to periphery. Peripapillary region images were taken at focal area 3 in all four quadrants; peripheral region images were taken at focal area 6 in all four quadrants, and four parafoveal images were taken directly adjacent to the fovea following quadrantal delineation, for total of 12 images taken per retina analyzed. (B) Image of temporal retina is shown highlighted in blue, with box 1 (parafovea), box 2 (peripapillary), and box 3 (periphery) showing locations of images gathered in this study.
Figure 1. Representative image of whole marmoset retina’s superficial vasculature, demonstrating retinal locations studied. Figure modified from Lin et al. [17]. (A) Control marmoset’s superficial vasculature within whole retina, visualized with Isolectin (green; ID: C16 Left eye; scale bar 1000 μm) and consisting of multiple 4× magnification images stitched together using Photoshop. During analysis, the eye was split into four quadrants: Temporal (outlined in blue, also quadrant where the fovea can be found (yellow circle)), Nasal (directly across the optic nerve from temporal quadrant), Superior, and Inferior quadrants. Each quadrant was further split into peripapillary (Pp) and peripheral (Ph) retinal regions. White boxes labeled 1 to 6 show that six focal areas of 40× magnification exist from optic nerve head to periphery. Peripapillary region images were taken at focal area 3 in all four quadrants; peripheral region images were taken at focal area 6 in all four quadrants, and four parafoveal images were taken directly adjacent to the fovea following quadrantal delineation, for total of 12 images taken per retina analyzed. (B) Image of temporal retina is shown highlighted in blue, with box 1 (parafovea), box 2 (peripapillary), and box 3 (periphery) showing locations of images gathered in this study.
Ijms 26 02824 g001
Figure 2. Parafoveal retinal ganglion cell density is significantly decreased in myopic marmosets. * p < 0.05, ** p < 0.01. Data are shown as box plot with SE as box and SD for whiskers. (A) Representative images of parafoveal ganglion cells stained with BRN3A are shown (red; scale bar, 50 μm). Representative image ID tags for control (top left: 6-month ID tag Z17 Left, control; top right: 12-month ID tag R19 Left) and myopic marmosets (bottom left: ID tag E19 Right; bottom right: ID tag F20 Left). (B) Ganglion cell density is significantly decreased in parafoveal retinas of myopic marmosets with both longer duration of treatment (10 months, p < 0.01) and shorter duration of treatment (4 months, p < 0.05). There was no significant difference between both groups of myopic marmosets.
Figure 2. Parafoveal retinal ganglion cell density is significantly decreased in myopic marmosets. * p < 0.05, ** p < 0.01. Data are shown as box plot with SE as box and SD for whiskers. (A) Representative images of parafoveal ganglion cells stained with BRN3A are shown (red; scale bar, 50 μm). Representative image ID tags for control (top left: 6-month ID tag Z17 Left, control; top right: 12-month ID tag R19 Left) and myopic marmosets (bottom left: ID tag E19 Right; bottom right: ID tag F20 Left). (B) Ganglion cell density is significantly decreased in parafoveal retinas of myopic marmosets with both longer duration of treatment (10 months, p < 0.01) and shorter duration of treatment (4 months, p < 0.05). There was no significant difference between both groups of myopic marmosets.
Ijms 26 02824 g002
Figure 3. Peripapillary retinal ganglion cell density is significantly decreased in myopic marmosets. * p < 0.05. Data are shown as box plot with SE as box and SD for whiskers. (A) Representative images of peripapillary ganglion cells stained with BRN3A are shown (red; scale bar, 50 μm). Representative image ID tags for control (top left: 6-month ID tag U19 Left, control; top right: 12-month ID tag Trike Right) and myopic marmosets (bottom left: ID tag E19 Left; bottom right: ID tag G20 Left). (B) Ganglion cell density is significantly decreased in peripapillary retinas of myopic marmosets with both longer duration of treatment (10 months, p < 0.05) and shorter duration of treatment (4 months, p < 0.05). There is a significant decrease in older myopic marmoset peripapillary retinal ganglion cell density compared to that of younger myopic marmosets (p < 0.05).
Figure 3. Peripapillary retinal ganglion cell density is significantly decreased in myopic marmosets. * p < 0.05. Data are shown as box plot with SE as box and SD for whiskers. (A) Representative images of peripapillary ganglion cells stained with BRN3A are shown (red; scale bar, 50 μm). Representative image ID tags for control (top left: 6-month ID tag U19 Left, control; top right: 12-month ID tag Trike Right) and myopic marmosets (bottom left: ID tag E19 Left; bottom right: ID tag G20 Left). (B) Ganglion cell density is significantly decreased in peripapillary retinas of myopic marmosets with both longer duration of treatment (10 months, p < 0.05) and shorter duration of treatment (4 months, p < 0.05). There is a significant decrease in older myopic marmoset peripapillary retinal ganglion cell density compared to that of younger myopic marmosets (p < 0.05).
Ijms 26 02824 g003
Figure 4. Peripheral retinal ganglion cell density is significantly decreased in myopic marmosets. * p < 0.05, ** p < 0.01. Data are shown as box plot with SE as box and SD for whiskers. (A) Representative images of peripheral ganglion cells stained with BRN3A are shown (red; scale bar, 50 μm). Representative image ID tags for control (top left: 6-month ID tag U19 Right, control; top right: 12-month ID tag R19 Left) and myopic marmosets (bottom left: ID tag E19 Left; bottom right: ID tag F20 Left). (B) Ganglion cell density is significantly decreased in peripheral retinas of myopic marmosets with both longer duration of treatment (10 months, p < 0.01) and shorter duration of treatment (4 months, p < 0.05). There is no significant difference between both groups of myopic marmosets (p > 0.05).
Figure 4. Peripheral retinal ganglion cell density is significantly decreased in myopic marmosets. * p < 0.05, ** p < 0.01. Data are shown as box plot with SE as box and SD for whiskers. (A) Representative images of peripheral ganglion cells stained with BRN3A are shown (red; scale bar, 50 μm). Representative image ID tags for control (top left: 6-month ID tag U19 Right, control; top right: 12-month ID tag R19 Left) and myopic marmosets (bottom left: ID tag E19 Left; bottom right: ID tag F20 Left). (B) Ganglion cell density is significantly decreased in peripheral retinas of myopic marmosets with both longer duration of treatment (10 months, p < 0.01) and shorter duration of treatment (4 months, p < 0.05). There is no significant difference between both groups of myopic marmosets (p > 0.05).
Ijms 26 02824 g004
Figure 5. PhNR Vmax amplitudes are significantly decreased in older myopic marmosets treated with negative-powered lenses for 10 months compared to age-matched controls. * p < 0.05, ** p < 0.01. Light blue signifies 6-month-old control marmosets; pink signifies 6-month-old myopic marmosets treated with negative lens wear for 4 months; dark blue signifies 12-month-old control marmosets; and red signifies 12-month-old myopic marmosets treated with negative lens wear for 10 months. (A) Naka–Rushton graph showing PhNR Vmax amplitudes at all stimulus intensities of both myopic cohorts and their age-matched controls (ANOVA p < 0.05). (B) PhNR Vmax amplitude is significantly decreased in myopic eyes treated for 10 months compared to age-matched controls (p < 0.01), but not significantly different in myopic eyes treated for 4 months compared to age-matched controls (p > 0.05). PhNR Vmax amplitude is significantly decreased in myopic eyes treated for 10 months compared to myopic eyes treated for 4 months (p < 0.05). Data are shown as box plot with SE as box and SD for whiskers.
Figure 5. PhNR Vmax amplitudes are significantly decreased in older myopic marmosets treated with negative-powered lenses for 10 months compared to age-matched controls. * p < 0.05, ** p < 0.01. Light blue signifies 6-month-old control marmosets; pink signifies 6-month-old myopic marmosets treated with negative lens wear for 4 months; dark blue signifies 12-month-old control marmosets; and red signifies 12-month-old myopic marmosets treated with negative lens wear for 10 months. (A) Naka–Rushton graph showing PhNR Vmax amplitudes at all stimulus intensities of both myopic cohorts and their age-matched controls (ANOVA p < 0.05). (B) PhNR Vmax amplitude is significantly decreased in myopic eyes treated for 10 months compared to age-matched controls (p < 0.01), but not significantly different in myopic eyes treated for 4 months compared to age-matched controls (p > 0.05). PhNR Vmax amplitude is significantly decreased in myopic eyes treated for 10 months compared to myopic eyes treated for 4 months (p < 0.05). Data are shown as box plot with SE as box and SD for whiskers.
Ijms 26 02824 g005
Table 1. Myopic marmosets initiated lens wear at 10 weeks old (72.0 ± 5.5 days) following an established protocol [81,82]. Daily morning contact lens insertion occurred between 8 and 10 am. The lights (700 lux) were turned on at 10 am after the lenses were inserted, and were subsequently removed 9 h later at lights-off each day (9 h of light/15 h of dark). The contact lenses were either a 3.6 or 3.8 mm base curve and a 6.5 mm diameter, made of methafilcon A (55% water content, Dk: 17), and fit 0.10 mm flatter than the flattest keratometry measurement. No corneal complications were observed in any of our treated myopic animals in this or earlier marmoset studies [81,82,83].
Table 1. Myopic marmosets initiated lens wear at 10 weeks old (72.0 ± 5.5 days) following an established protocol [81,82]. Daily morning contact lens insertion occurred between 8 and 10 am. The lights (700 lux) were turned on at 10 am after the lenses were inserted, and were subsequently removed 9 h later at lights-off each day (9 h of light/15 h of dark). The contact lenses were either a 3.6 or 3.8 mm base curve and a 6.5 mm diameter, made of methafilcon A (55% water content, Dk: 17), and fit 0.10 mm flatter than the flattest keratometry measurement. No corneal complications were observed in any of our treated myopic animals in this or earlier marmoset studies [81,82,83].
6 m Control ID, EyeEye Length (mm)Refraction (D)GenderAge (Days)6 m Myope ID, EyeEye Length (mm)Refraction (D)GenderAge (Days)
U19, Right9.83−1.73Male249U17, Right10.24−3.59Male220
U19, Left9.79−2.24Male249E19, Right10.86−4.29Male221
Z17, Left9.81−0.41Male214E19, Left10.80−3.64Male221
AVG ± SD9.81 ± 0.0−1.46 ± 0.9 237.33 ± 20.2AVG ± SD10.63 ± 0.3−3.84 ± 0.4 220.67 ± 0.6
p < 0.05p < 0.05 p > 0.05
12 m Control ID, EyeEye Length (mm)Refraction (D)GenderAge (Days)12 m Myope ID, EyeEye Length (mm)Refraction (D)GenderAge (Days)
Trike, Right10.22−1.12Female382F20, Left11.12−7.86Male396
R19, Left10.22−1.04Male381G20, Left11.33−5.715Female396
P16, Right11.21+1.22Female396H20, Left11.05−11.70Female420
AVG ± SD10.56 ± 0.5−0.31 ± 1.3 386.33 ± 8.4AVG ± SD11.17 ± 0.1−8.42 ± 3.0 404 ± 13.9
p < 0.001p < 0.001 p > 0.05
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lin, C.R.; Ablordeppey, R.K.; Benavente-Perez, A. Sustained Experimental Myopia Exacerbates the Effect of Eye Growth on Retinal Ganglion Cell Density and Function. Int. J. Mol. Sci. 2025, 26, 2824. https://doi.org/10.3390/ijms26062824

AMA Style

Lin CR, Ablordeppey RK, Benavente-Perez A. Sustained Experimental Myopia Exacerbates the Effect of Eye Growth on Retinal Ganglion Cell Density and Function. International Journal of Molecular Sciences. 2025; 26(6):2824. https://doi.org/10.3390/ijms26062824

Chicago/Turabian Style

Lin, Carol Ren, Reynolds Kwame Ablordeppey, and Alexandra Benavente-Perez. 2025. "Sustained Experimental Myopia Exacerbates the Effect of Eye Growth on Retinal Ganglion Cell Density and Function" International Journal of Molecular Sciences 26, no. 6: 2824. https://doi.org/10.3390/ijms26062824

APA Style

Lin, C. R., Ablordeppey, R. K., & Benavente-Perez, A. (2025). Sustained Experimental Myopia Exacerbates the Effect of Eye Growth on Retinal Ganglion Cell Density and Function. International Journal of Molecular Sciences, 26(6), 2824. https://doi.org/10.3390/ijms26062824

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop